BrightPath Biotherapeutics4594 
$0.36-1.92%24h
-1.92%24h
Global rank29459
Market cap$21.41M
Change 7d0.00%
YTD Performance-40.70%
SP500 benchmarkUnderperform
P/E-0.01
P/S576.26
Revenue$37.16K
Earnings-$10.45M
Dividend yield-
BrightPath Biotherapeutics Revenue data
According to BrightPath Biotherapeutics latest financial reports the company had revenue of $37.16K in 2023-03-31, a -65.73% decrease from 2022. BrightPath Biotherapeutics highest revenue was $108.43K in 2022.
Revenue history for BrightPath Biotherapeutics from 2020 to 2024
-
Value:-
BrightPath Biotherapeutics revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $37.16K | -65.73% |
| 2022 | $108.43K | 515.34% |
| 2021 | $17.62K | -77.84% |
| 2020 | $79.52K | - |
View the top revenue stocks 
